Cas no 1159511-52-0 ((2-methyl-2H-indazol-5-yl)methanol)
(2-methyl-2H-indazol-5-yl)methanol Chemical and Physical Properties
Names and Identifiers
-
- (2-methylindazol-5-yl)methanol
- CTK8A2942
- (2-methyl-2H-indazol-5-yl)methanol
- OR30866
- AG-C-05085
- PB10985
- SureCN3436381
- 5-(Hydroxymethyl)-2-methyl-2H-indazole
- SCHEMBL3436381
- 2-Methyl-5-(hydroxymethyl)-2H-indazole
- 2H-Indazole-5-methanol, 2-methyl-
- AKOS006318231
- DB-393387
- AMY34363
- P11339
- 2-Methyl-2H-indazole-5-methanol
- 1159511-52-0
- CS-0053517
- W-204867
- AS-50887
- J-500854
- MFCD12028587
-
- MDL: MFCD12028587
- Inchi: 1S/C9H10N2O/c1-11-5-8-4-7(6-12)2-3-9(8)10-11/h2-5,12H,6H2,1H3
- InChI Key: QZYREQWDFMCGNO-UHFFFAOYSA-N
- SMILES: OCC1C=CC2C(=CN(C)N=2)C=1
Computed Properties
- Exact Mass: 162.079312947g/mol
- Monoisotopic Mass: 162.079312947g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 12
- Rotatable Bond Count: 1
- Complexity: 163
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 0.7
- Topological Polar Surface Area: 38?2
(2-methyl-2H-indazol-5-yl)methanol Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Chemenu | CM233812-100mg |
5-(Hydroxymethyl)-2-methyl-2H-indazole |
1159511-52-0 | 95+% | 100mg |
$200 | 2021-08-04 | |
| Chemenu | CM233812-250mg |
5-(Hydroxymethyl)-2-methyl-2H-indazole |
1159511-52-0 | 95+% | 250mg |
$307 | 2021-08-04 | |
| Chemenu | CM233812-1g |
5-(Hydroxymethyl)-2-methyl-2H-indazole |
1159511-52-0 | 95+% | 1g |
$665 | 2021-08-04 | |
| TRC | M221340-10mg |
(2-Methyl-2H-indazol-5-yl)methanol |
1159511-52-0 | 10mg |
$ 50.00 | 2022-06-04 | ||
| TRC | M221340-50mg |
(2-Methyl-2H-indazol-5-yl)methanol |
1159511-52-0 | 50mg |
$ 95.00 | 2022-06-04 | ||
| TRC | M221340-100mg |
(2-Methyl-2H-indazol-5-yl)methanol |
1159511-52-0 | 100mg |
$ 160.00 | 2022-06-04 | ||
| SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd. | M172223-1g |
(2-methyl-2H-indazol-5-yl)methanol |
1159511-52-0 | 97% | 1g |
¥1804.90 | 2023-09-01 | |
| Apollo Scientific | OR30866-100mg |
5-(Hydroxymethyl)-2-methyl-2H-indazole |
1159511-52-0 | 95% | 100mg |
£35.00 | 2025-02-20 | |
| Apollo Scientific | OR30866-250mg |
5-(Hydroxymethyl)-2-methyl-2H-indazole |
1159511-52-0 | 95% | 250mg |
£78.00 | 2025-02-20 | |
| Chemenu | CM233812-100mg |
5-(Hydroxymethyl)-2-methyl-2H-indazole |
1159511-52-0 | 95%+ | 100mg |
$*** | 2023-04-03 |
(2-methyl-2H-indazol-5-yl)methanol Related Literature
-
Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
-
Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
-
Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
-
Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
-
Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
Additional information on (2-methyl-2H-indazol-5-yl)methanol
Introduction to (2-methyl-2H-indazol-5-yl)methanol (CAS No. 1159511-52-0)
(2-methyl-2H-indazol-5-yl)methanol, with the CAS number 1159511-52-0, is a significant compound in the field of pharmaceutical chemistry and bioorganic synthesis. This heterocyclic alcohol has garnered attention due to its structural versatility and potential applications in drug development. The indazole core, a fused bicyclic system consisting of a benzene ring and a pyrrole ring, is known for its role in various biologically active molecules. The presence of a methyl group at the 2-position and a hydroxymethyl group at the 5-position further enhances its synthetic utility and reactivity.
The compound's unique structural features make it a valuable intermediate in the synthesis of more complex molecules. Its indazole moiety is particularly interesting because it can serve as a scaffold for designing molecules with specific biological activities. For instance, indazole derivatives have been explored for their potential in treating neurological disorders, inflammation, and infectious diseases. The hydroxymethyl group provides a site for further functionalization, allowing chemists to introduce additional pharmacophores or link the molecule to other therapeutic agents.
Recent research has highlighted the importance of (2-methyl-2H-indazol-5-yl)methanol in the development of novel therapeutic agents. One notable area of investigation is its role as a precursor in the synthesis of kinase inhibitors. Kinases are enzymes that play crucial roles in cell signaling pathways, and their dysregulation is associated with various diseases, including cancer. By modifying the indazole core, researchers have been able to design molecules that selectively inhibit specific kinases, thereby offering new treatment strategies.
In addition to its applications in kinase inhibition, (2-methyl-2H-indazol-5-yl)methanol has been studied for its potential in antimicrobial therapy. The indazole scaffold is known to exhibit broad-spectrum antimicrobial activity, and modifications to this core can enhance or tailor these properties. For example, studies have shown that certain indazole derivatives can inhibit the growth of Gram-positive and Gram-negative bacteria, as well as fungi. This makes (2-methyl-2H-indazol-5-yl)methanol a promising candidate for developing new antimicrobial agents to combat drug-resistant pathogens.
The synthesis of (2-methyl-2H-indazol-5-yl)methanol involves multi-step organic reactions that highlight its synthetic utility. One common approach involves the condensation of acetone with an indazole derivative followed by reduction. This method leverages the reactivity of ketones and indazole intermediates to form the desired alcohol. Alternatively, palladium-catalyzed cross-coupling reactions can be employed to introduce the hydroxymethyl group at the 5-position of the indazole ring. These synthetic strategies demonstrate the flexibility and adaptability of (2-methyl-2H-indazol-5-yl)methanol as a building block in medicinal chemistry.
The pharmacological properties of (2-methyl-2H-indazol-5-yl)methanol are further enhanced by its ability to undergo various chemical transformations. For instance, it can be oxidized to form an aldehyde or ketone, which can then be used in subsequent reactions such as nucleophilic addition or condensation reactions. Additionally, it can be converted into esters or amides by reacting with carboxylic acids or acid chlorides. These transformations provide chemists with a wide range of options for designing molecules with specific biological activities.
In conclusion, (2-methyl-2H-indazol-5-yl)methanol (CAS No. 1159511-52-0) is a versatile compound with significant potential in pharmaceutical research and development. Its unique structural features make it an excellent intermediate for synthesizing biologically active molecules, particularly those targeting kinases and antimicrobial pathogens. The compound's synthetic utility and pharmacological properties continue to drive innovation in drug discovery, making it a valuable asset for researchers in the field of medicinal chemistry.
1159511-52-0 ((2-methyl-2H-indazol-5-yl)methanol) Related Products
- 1071433-06-1(2-methyl-2H-indazole-4-carboxylic acid)
- 1092961-08-4((1-Methyl-1H-indazol-7-YL)methanol)
- 1092961-10-8((1-Methyl-1H-indazol-6-YL)methanol)
- 1197943-94-4(2-methyl-2H-indazole-5-carboxylic acid)
- 1071433-05-0(1-Methyl-1H-indazole-4-carboxylic acid)
- 1092961-11-9((1-Methyl-1H-indazol-5-YL)methanol)
- 1031417-46-5(2-Methyl-2H-indazole-6-carboxylic acid)
- 1092961-12-0((1-Methyl-1H-indazol-4-YL)methanol)
- 1031417-77-2(1-Methyl-1H-indazole-6-carboxylic acid)
- 1176754-31-6(1-Methyl-1H-indazole-5-carboxylic acid)